DEFB132 | Defensin, beta 132 | Predicted secreted proteins
| | | | | Group enriched |
MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
C14orf180 | Chromosome 14 open reading frame 180 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
KCNIP2 | Kv channel interacting protein 2 | Predicted intracellular proteins
| | | | | Group enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
EN1 | Engrailed homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
HRASLS5 | HRAS-like suppressor family, member 5 | Predicted intracellular proteins
| | | | | Group enriched |
PRRT4 | Proline-rich transmembrane protein 4 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH20 | Cadherin 20, type 2 | Predicted membrane proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
TBX15 | T-box 15 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SAA2-SAA4 | SAA2-SAA4 readthrough | Predicted membrane proteins
| | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ARC | Activity-regulated cytoskeleton-associated protein | Predicted intracellular proteins
| | | | | Group enriched |
G0S2 | G0/G1 switch 2 | Predicted intracellular proteins
| | | | | Group enriched |
PPP1R1A | Protein phosphatase 1, regulatory (inhibitor) subunit 1A | Predicted intracellular proteins
| | | | | Group enriched |
RP11-599B13.6 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000464383} | Predicted membrane proteins
| | | | | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ALPK3 | Alpha-kinase 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | Predicted intracellular proteins
| | | | | Group enriched |
DGAT2 | Diacylglycerol O-acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
EMP1 | Epithelial membrane protein 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
GPIHBP1 | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
MESP1 | Mesoderm posterior basic helix-loop-helix transcription factor 1 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
THRSP | Thyroid hormone responsive | Predicted intracellular proteins
| | | | | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
LBP | Lipopolysaccharide binding protein | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
NNAT | Neuronatin | Predicted membrane proteins
| | | | | Group enriched |
RAD51L3-RFFL | HCG2039718, isoform CRA_g {ECO:0000313|EMBL:EAW80179.1}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000466834} | Predicted intracellular proteins
| | | | | Group enriched |
THBS4 | Thrombospondin 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |